BRKR

Bruker Corporation

$62.24

-6.46%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.

Source: Yahoo Finance
AI summary

Price & performance

1M-8.8%
3M-0.3%
YTD+16.6%
1Y+47.4%
52-week range—
Beta1.20
Full chart and returns against a benchmark

Q-Score

49/ 100

Quality against peers; 50 is the peer median.

Growth47
Risk60
Performance47
Valuation46
Profitability57
Leverage48
Sentiment36
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$3.4B+2.1%
Net income-$8.6M-107.6%
Net margin-0.3%-3.6 pts
Historical fundamentals

Revenue exposure

74%of revenue from outside the US
Other countries28%
United States26%
Other countries16%
Largest customer10%
Regions, segments, customers and suppliers

Valuation

BRKRIndustryP/E—29.61P/S2.713.49EV/EBITDA69.9118.38P/B4.123.39PEG——
Dividend yield0.32%
Every valuation metric

Earnings

Nov 4next report, before the open
EPS estimate$0.42
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate